AccuraGen Holding Limited

AccuraGen uniquely employs rolling-circle amplification to perform consensus-based concatemer error correction in liquid biopsy. The fundamental of our technology ensures a high conversion rate and minimizes the proliferations of errors. We optimized our assay to detect a breadth of genetic alterations with a sensitivity approaching the physical limit and a specificity as much as 100x better than benchmark.